Bank of New York Mellon’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $895K | Buy |
135,227
+15,178
| +13% | +$100K | ﹤0.01% | 3176 |
|
|
2025
Q1 | $1.1M | Sell |
120,049
-5,006
| -4% | -$45.8K | ﹤0.01% | 3001 |
|
|
2024
Q4 | $1.31M | Buy |
125,055
+34,036
| +37% | +$357K | ﹤0.01% | 2963 |
|
|
2024
Q3 | $1.09M | Sell |
91,019
-21,458
| -19% | -$256K | ﹤0.01% | 3087 |
|
|
2024
Q2 | $647K | Buy |
+112,477
| New | +$647K | ﹤0.01% | 3431 |
|
|
2024
Q1 | – | Sell |
-15,042
| Closed | -$79.3K | – | 4171 |
|
|
2023
Q4 | $79.3K | Sell |
15,042
-77,251
| -84% | -$407K | ﹤0.01% | 4117 |
|
|
2023
Q3 | $305K | Buy |
92,293
+3,434
| +4% | +$11.3K | ﹤0.01% | 3787 |
|
|
2023
Q2 | $257K | Sell |
88,859
-94,334
| -51% | -$273K | ﹤0.01% | 3889 |
|
|
2023
Q1 | $196K | Sell |
183,193
-10,050
| -5% | -$10.8K | ﹤0.01% | 3930 |
|
|
2022
Q4 | $504K | Sell |
193,243
-16,023
| -8% | -$41.8K | ﹤0.01% | 3534 |
|
|
2022
Q3 | $1.47M | Buy |
209,266
+10,099
| +5% | +$70.7K | ﹤0.01% | 3023 |
|
|
2022
Q2 | $1.36M | Buy |
199,167
+45,460
| +30% | +$310K | ﹤0.01% | 3048 |
|
|
2022
Q1 | $2.17M | Buy |
153,707
+4,382
| +3% | +$61.8K | ﹤0.01% | 2884 |
|
|
2021
Q4 | $2.16M | Buy |
149,325
+90,694
| +155% | +$1.31M | ﹤0.01% | 2941 |
|
|
2021
Q3 | $830K | Buy |
58,631
+41,113
| +235% | +$582K | ﹤0.01% | 3501 |
|
|
2021
Q2 | $308K | Buy |
17,518
+1,417
| +9% | +$24.9K | ﹤0.01% | 3954 |
|
|
2021
Q1 | $246K | Buy |
+16,101
| New | +$246K | ﹤0.01% | 3984 |
|